FLAD1 and neoplasm: The sex, tumor size, tumor grade, metastasis, infiltration status and Ki-67 expression level were not of significant difference between the FLAD1-positive and the FLAD1-negative group (Table 1), though the majority of patients had pT3 disease (79.2%).